| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/JTO.0B013E3181B26F8E |
| P698 | PubMed publication ID | 19668013 |
| P2093 | author name string | Lisa A Rybicki | |
| Jerrold P Saxton | |||
| Thomas W Rice | |||
| Gregory M M Videtic | |||
| David P Mason | |||
| Sudish C Murthy | |||
| David J Adelstein | |||
| Cristina P Rodriguez | |||
| Denise I Ives | |||
| P433 | issue | 10 | |
| P921 | main subject | phase II clinical trial | Q42824440 |
| chemoradiotherapy | Q5090613 | ||
| P304 | page(s) | 1264-1269 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
| P1476 | title | Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction | |
| P478 | volume | 4 |
| Q30537735 | Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction |
| Q45863331 | Adjuvant radiation therapy and lymphadenectomy in esophageal cancer: a SEER database analysis |
| Q43129996 | Analysis of new N-category on prognosis of oesophageal cancer with positive lymph nodes in a Chinese population |
| Q55033047 | Customization of therapy for gastroesophageal adenocarcinoma patients. |
| Q42342010 | Do we have enough evidence for adjuvant postoperative chemoradiation in esophageal cancer? |
| Q38010632 | Multi-modality therapy for cancer of the esophagus and GE junction |
| Q58755645 | Nomograms for predicting risk of locoregional recurrence and distant metastases for esophageal cancer patients after radical esophagectomy |
| Q54484856 | Phase II Trial of Intensity-Modulated Radiotherapy Concurrent With Chemotherapy for Postoperative Node-Positive Esophageal Squamous Cell Carcinoma. |
| Q37455214 | Postoperative chemoradiotherapy improves survival in patients with stage II-III esophageal squamous cell carcinoma: An analysis of clinical outcomes |
| Q24202240 | Postoperative chemotherapy or radiotherapy for esophageal cancer |
| Q54169017 | Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study. |
| Q35496579 | Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy |
| Q36898394 | Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer |
| Q38027516 | Radiation therapy in the postoperative management of esophageal cancer |
| Q36611286 | Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia. |
| Q42287321 | Saudi Oncology Society clinical management guideline series. Esophageal cancer 2014. |
| Q36666677 | The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen |
| Q36544823 | Tolerance and dose-volume relationship of intrathoracic stomach irradiation after esophagectomy for patients with thoracic esophageal squamous cell carcinoma |
| Q42011346 | Update: modern approaches to the treatment of localized esophageal cancer |
| Q47639150 | Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma |
Search more.